EUCI — Eurocine Vaccines AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK22.39m
- SEK21.08m
Annual cashflow statement for Eurocine Vaccines AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.9 | -8.91 | -18.2 | -20.1 | -18.4 |
| Non-Cash Items | — | 0 | — | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.805 | -0.056 | -19.9 | 16.7 | -0.82 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -20.1 | -8.96 | -38.1 | -3.45 | -19.2 |
| Financing Cash Flow Items | -3.56 | -5.43 | -5.21 | -0.631 | -1.83 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 15.3 | 35.9 | 20.1 | 3.82 | 5.98 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.72 | 27 | -18.1 | 0.374 | -13.2 |